Neratinib
![]() |
- ₹0
- Product name: Neratinib
- CAS: 698387-09-6
- MF: C30H29ClN6O3
- MW: 557.04
- EINECS:811-237-1
- MDL Number:MFCD09752958
- Synonyms:Neratinib(HKI-272);(2E)-N-[4-[[3-chloro-4-(2-pyridinylMethoxy)phenyl]aMino]-3-cyano-7-ethoxy-6-quinolinyl]-4-(diMethylaMino)-2-butenaMide;neratinib;(E)-N-[4-[3-Chloro-4-[(2-pyridinyl)methoxy]anilino]-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-2-butenamide;N-(4-(3-Chloro-4-(2-pyridinylmethoxy)anilino)-3-cyano-7-ethoxy-6-quinolyl)-4-(dimethylamino)-2-butenamide;Unii-jjh94R3pwb;(2e)-n-(4-((3-chloro-4-((pyridin-2-yl)Methoxy)phenyl)aMino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(diMethylaMino)but-2-enaMide neratinib;HKI-272 Neratinib
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|
Properties
Melting point :185-187°C
Boiling point :757.0±60.0 °C(Predicted)
Density :1.33
storage temp. :Refrigerator
solubility :Chloroform (Slightly), DMSO (Slightly, Heated, Sonicated), Methanol (Slightly, Heated)
form :Off-white solid.
pka :12.37±0.43(Predicted)
color :Pale Yellow to Yellow
Boiling point :757.0±60.0 °C(Predicted)
Density :1.33
storage temp. :Refrigerator
solubility :Chloroform (Slightly), DMSO (Slightly, Heated, Sonicated), Methanol (Slightly, Heated)
form :Off-white solid.
pka :12.37±0.43(Predicted)
color :Pale Yellow to Yellow
Safety Information
Symbol(GHS): |
![]() |
|||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Danger | |||||||||||||||||||||
Hazard statements: |
|
|||||||||||||||||||||
Precautionary statements: |
|
Description
The receptor tyrosine kinase HER2 (ErbB2) is a key component of epidermal growth factor receptor complexes that are known to have central roles in cell proliferation and cancer. Neratinib is an orally active, irreversible inhibitor of the HER2 kinase (IC50 = 59 nM). It also potently inhibits several mutants of HER2 and shows 10-fold or greater selectivity over a wide variety of other kinases. As an irreversible inhibitor, neratinib may circumvent acquired resistance developed against reversible inhibitors, including gefitinib . Neratinib has been evaluated in clinical trials against cancers characterized by HER2 overexpression or HER2 activating mutations.More related product prices
Afatinib (BIBW 2992) Crizotinib Ibrutinib ABT 263 Bortezomib Gefitinib Paclitaxel Axitinib Lenvatinib 848133-76-6 AZD-9291 EthoxyquinRelated product price
- Crizotinib
₹13174.03 - Bortezomib
₹12940 - Gefitinib
₹4200-45778.93
Suppliers and manufacturers
A.J Chemicals
CLEARSYNTH LABS LTD.
Pharmaffiliates Analytics and Synthetics P. Ltd
SynZeal Research Pvt Ltd
Clearsynth Labs
DR. Madhukar Pharmaceuticals (P) Limited
Archerchem Healthcare Pvt., Ltd. (part of Archerchem Group)
CLEANCHEM LABORATORIES LLP
Pharma Affiliates